These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30737795)

  • 1. Perioperative outcomes of extensive bowel resection during cytoreductive surgery in patients with advanced ovarian cancer.
    Son JH; Kong TW; Paek J; Chang SJ; Ryu HS
    J Surg Oncol; 2019 Jun; 119(7):1011-1015. PubMed ID: 30737795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive and Prognostic Implication of Bowel Resections During Primary Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer.
    Bartl T; Schwameis R; Stift A; Bachleitner-Hofmann T; Reinthaller A; Grimm C; Polterauer S
    Int J Gynecol Cancer; 2018 Nov; 28(9):1664-1671. PubMed ID: 30371563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.
    Gockley AA; Fiascone S; Hicks Courant K; Pepin K; Del Carmen M; Clark RM; Goldberg J; Horowitz N; Berkowitz R; Worley M
    Int J Gynecol Cancer; 2019 Mar; 29(3):585-592. PubMed ID: 30833444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The surgical outcomes and perioperative complications of bowel resection as part of debulking surgery of advanced ovarian cancer patients.
    Ye S; Wang Y; Chen L; Wu X; Yang H; Xiang L
    BMC Surg; 2022 Mar; 22(1):81. PubMed ID: 35246104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtotal Colectomy as Part of Debulking Surgery for Advanced-stage Ovarian Cancer.
    Bacalbasa N; Diaconu C; Iliescu L; Dima S; Bratu OG; Cretoiu D; Neacsu A; Filipescu A; Savu C; Balescu I
    In Vivo; 2020; 34(5):2757-2761. PubMed ID: 32871811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of type and number of bowel resections on anastomotic leakage risk in advanced ovarian cancer surgery.
    Grimm C; Harter P; Alesina PF; Prader S; Schneider S; Ataseven B; Meier B; Brunkhorst V; Hinrichs J; Kurzeder C; Heitz F; Kahl A; Traut A; Groeben HT; Walz M; du Bois A
    Gynecol Oncol; 2017 Sep; 146(3):498-503. PubMed ID: 28610745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morbidity of multiple bowel resection compared to single bowel resection after debulking surgery for ovarian cancer.
    Tozzi R; Casarin J; Baysal A; Pinelli C; Matak L; Ghanbarzadeh N; Alazzam M; Garruto-Campanile R; Majd HS; Kilic Y; Morotti M
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():215-219. PubMed ID: 31326636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does timing of intraperitoneal chemotherapy initiation following primary cytoreductive surgery with bowel resection impact outcomes in patients with advanced ovarian cancer?
    Nica A; Covens A; Parra-Herran C; May T
    Gynecol Oncol; 2020 Sep; 158(3):622-630. PubMed ID: 32561124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National trends in bowel and upper abdominal procedures in ovarian cancer surgery.
    Dottino JA; He W; Sun CC; Zhao H; Fu S; Rauh-Hain JA; Suidan RS; Lu KH; Giordano SH; Meyer LA
    Int J Gynecol Cancer; 2020 Aug; 30(8):1195-1202. PubMed ID: 32616627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of posterior rectal dissection techniques during rectosigmoid colon resection as part of cytoreductive surgery in patients with epithelial ovarian cancer: Close rectal dissection versus total mesorectal excision.
    Son JH; Kim J; Shim J; Kong TW; Paek J; Chang SJ; Ryu HS
    Gynecol Oncol; 2019 May; 153(2):362-367. PubMed ID: 30846223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectosigmoidectomy and Douglas Peritonectomy in the Management of Serosal Implants in Advanced-Stage Ovarian Cancer Surgery: Survival and Surgical Outcomes.
    Erkilinç S; Karataşli V; Demir B; Çakir İ; Can B; Karadeniz T; Gökçü M; Sanci M
    Int J Gynecol Cancer; 2018 Nov; 28(9):1699-1705. PubMed ID: 30371561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bowel resection or repair at the time of cytoreductive surgery for ovarian malignancy is associated with increased complication rate: An ACS-NSQIP study.
    Bernard L; Boucher J; Helpman L
    Gynecol Oncol; 2020 Sep; 158(3):597-602. PubMed ID: 32641239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total or subtotal colectomy in patients undergoing surgery for primary or recurrent epithelial ovarian cancer.
    Oseledchyk A; Abramian A; Kaiser C; Debald M; Domröse C; Kiefer N; Putensen C; Pantelis D; Kuhn W; Schäfer N; Keyver-Paik MD
    Oncol Res Treat; 2014; 37(9):448-54. PubMed ID: 25231684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical and oral antibiotic bowel preparation in ovarian cancer debulking: Are we lowering or just trading surgical complications?
    Wang CC; Al-Rubaye R; Tran V; Montemorano L; Al-Niaimi A
    Gynecol Oncol; 2022 Jul; 166(1):76-84. PubMed ID: 35589434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Analysis of Long-Term Outcomes in Patients Treated by Extensive Bowel Resection Due to Advanced Ovarian Cancer Relative to the Effectiveness of Surgery.
    Lepinay K; Szubert S; Lewandowska A; Sierant A; Wicherek L
    Gynecol Obstet Invest; 2020; 85(2):159-166. PubMed ID: 31747661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total rectosigmoidectomy versus partial rectal resection in primary debulking surgery for advanced ovarian cancer.
    Plotti F; Montera R; Aloisi A; Scaletta G; Capriglione S; Luvero D; De Cicco Nardone C; Basile S; Benedetti Panici P; Angioli R
    Eur J Surg Oncol; 2016 Mar; 42(3):383-90. PubMed ID: 26725211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Outcomes in Bowel Resections by Gynecologic Oncologists Versus General Surgeons During Maximal Cytoreductive Surgery for Advanced Ovarian Cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3006).
    Kim MS; Lee AJ; Shim SH; Jang EB; Kim NK; Kim MK; Suh DH; Kim J; Son JH; Kong TW; Chang SJ; Hwang DW; Park SJ; Kim HS; Yoo JG; Lee SJ; Lee YY
    Ann Surg Oncol; 2024 Sep; 31(9):6040-6047. PubMed ID: 38961041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer.
    Gillette-Cloven N; Burger RA; Monk BJ; McMeekin DS; Vasilev S; DiSaia PJ; Kohler MF
    J Am Coll Surg; 2001 Dec; 193(6):626-32. PubMed ID: 11768679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: Analysis and management of complications in upper abdominal surgery.
    Benedetti Panici P; Di Donato V; Fischetti M; Casorelli A; Perniola G; Musella A; Marchetti C; Palaia I; Berloco P; Muzii L
    Gynecol Oncol; 2015 Jun; 137(3):406-11. PubMed ID: 25824857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic Resection as Part of Cytoreductive Surgery in Advanced-stage and Recurrent Epithelial Ovarian Cancer--A Single-center Experience.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Jul; 35(7):4125-9. PubMed ID: 26124365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.